Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Profit After Tax (2022 - 2025)

Bioregenx has reported Profit After Tax over the past 4 years, most recently at -$1.0 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 94.47% year-over-year to -$1.0 million; the TTM value through Dec 2025 reached -$1.5 million, up 93.3%, while the annual FY2025 figure was -$1.5 million, 93.3% up from the prior year.
  • Profit After Tax for Q4 2025 was -$1.0 million at Bioregenx, down from -$80565.0 in the prior quarter.
  • Over five years, Profit After Tax peaked at -$2191.0 in Q3 2022 and troughed at -$18.4 million in Q4 2024.
  • A 4-year average of -$1.8 million and a median of -$261801.0 in 2023 define the central range for Profit After Tax.
  • Biggest five-year swings in Profit After Tax: plummeted 114871.93% in 2023 and later surged 94.47% in 2025.
  • Year by year, Profit After Tax stood at -$5535.0 in 2022, then tumbled by 4538.63% to -$256748.0 in 2023, then plummeted by 7066.78% to -$18.4 million in 2024, then surged by 94.47% to -$1.0 million in 2025.
  • Business Quant data shows Profit After Tax for BRGX at -$1.0 million in Q4 2025, -$80565.0 in Q3 2025, and -$178345.0 in Q2 2025.